These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1260 related items for PubMed ID: 18438838

  • 1. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E, Kedersha N, Tohidast-Akrad M, Karlhofer FM, Stummvoll G, Zimmermann C, Ulrich W, Guiducci S, Hoefler E, Aringer M, Schett G, Matucci-Cerinic M, Smolen JS, Steiner G.
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [Abstract] [Full Text] [Related]

  • 2. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K, Hoch S, Dima C, Varga J, Teodorescu M.
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [Abstract] [Full Text] [Related]

  • 3. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 4. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P, De Andrea M, Migliaretti G, Trapani C, Landolfo S, Gariglio M.
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [Abstract] [Full Text] [Related]

  • 5. Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations.
    Kodera M, Hayakawa I, Komura K, Yanaba K, Hasegawa M, Takehara K, Sato S.
    J Rheumatol; 2005 Apr; 32(4):629-36. PubMed ID: 15801017
    [Abstract] [Full Text] [Related]

  • 6. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR, Simpson DF, Hurley BL, Matsuura E.
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [Abstract] [Full Text] [Related]

  • 7. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [Abstract] [Full Text] [Related]

  • 8. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus.
    Reichlin M, Fesmire J, Quintero-Del-Rio AI, Wolfson-Reichlin M.
    Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237
    [Abstract] [Full Text] [Related]

  • 9. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M, Vidali M, De Andrea M, Azzimonti B, Airò P, D'Ambrosio R, Riboldi P, Meroni PL, Albano E, Shoenfeld Y, Gariglio M, Landolfo S.
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [Abstract] [Full Text] [Related]

  • 10. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y, Ogawa F, Iwata Y, Komura K, Muroi E, Hara T, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 12. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases.
    Decker P, Briand JP, de Murcia G, Pero RW, Isenberg DA, Muller S.
    Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745
    [Abstract] [Full Text] [Related]

  • 13. Autoantibodies specific for alpha-enolase in systemic autoimmune disorders.
    Pratesi F, Moscato S, Sabbatini A, Chimenti D, Bombardieri S, Migliorini P.
    J Rheumatol; 2000 Jan; 27(1):109-15. PubMed ID: 10648026
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
    Půtová I, Dostal C, Becvar R.
    Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
    [Abstract] [Full Text] [Related]

  • 15. Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.
    Hara T, Ogawa F, Muroi E, Komura K, Takenaka M, Hasegawa M, Fujimoto M, Sato S.
    J Rheumatol; 2008 Mar; 35(3):451-7. PubMed ID: 18203319
    [Abstract] [Full Text] [Related]

  • 16. Over-expression of TATA binding protein (TBP) and p53 and autoantibodies to these antigens are features of systemic sclerosis, systemic lupus erythematosus and overlap syndromes.
    Chauhan R, Handa R, Das TP, Pati U.
    Clin Exp Immunol; 2004 Jun; 136(3):574-84. PubMed ID: 15147363
    [Abstract] [Full Text] [Related]

  • 17. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Jun; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM, Barr SG, Martin LO, Chan EK, Fritzler MJ.
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [Abstract] [Full Text] [Related]

  • 19. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 20. Anti-topoisomerase I (anti-Scl-70) antibodies in patients with systemic lupus erythematosus.
    Gussin HA, Ignat GP, Varga J, Teodorescu M.
    Arthritis Rheum; 2001 Feb; 44(2):376-83. PubMed ID: 11229469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.